JPS53149928A - Taurine derivative having nervous muscle activity - Google Patents

Taurine derivative having nervous muscle activity

Info

Publication number
JPS53149928A
JPS53149928A JP3398978A JP3398978A JPS53149928A JP S53149928 A JPS53149928 A JP S53149928A JP 3398978 A JP3398978 A JP 3398978A JP 3398978 A JP3398978 A JP 3398978A JP S53149928 A JPS53149928 A JP S53149928A
Authority
JP
Japan
Prior art keywords
muscle activity
taurine derivative
nervous muscle
nervous
taurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3398978A
Other languages
English (en)
Other versions
JPS6256867B2 (ja
Inventor
Pieeru Doyuratsushiyu Jiyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cooperation Pharmaceutique Francaise SAS
Original Assignee
Cooperation Pharmaceutique Francaise SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperation Pharmaceutique Francaise SAS filed Critical Cooperation Pharmaceutique Francaise SAS
Publication of JPS53149928A publication Critical patent/JPS53149928A/ja
Publication of JPS6256867B2 publication Critical patent/JPS6256867B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP3398978A 1977-03-23 1978-03-23 Taurine derivative having nervous muscle activity Granted JPS53149928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7708692A FR2384751A1 (fr) 1977-03-23 1977-03-23 Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Publications (2)

Publication Number Publication Date
JPS53149928A true JPS53149928A (en) 1978-12-27
JPS6256867B2 JPS6256867B2 (ja) 1987-11-27

Family

ID=9188473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3398978A Granted JPS53149928A (en) 1977-03-23 1978-03-23 Taurine derivative having nervous muscle activity

Country Status (17)

Country Link
US (3) US4199601A (ja)
JP (1) JPS53149928A (ja)
AT (1) AT356637B (ja)
AU (1) AU523705B2 (ja)
BE (1) BE865163A (ja)
CA (1) CA1095930A (ja)
CH (1) CH629479A5 (ja)
DE (1) DE2810918C2 (ja)
ES (1) ES468201A1 (ja)
FR (1) FR2384751A1 (ja)
GB (1) GB1599962A (ja)
GR (1) GR62093B (ja)
IT (1) IT1111455B (ja)
NL (1) NL7803131A (ja)
OA (1) OA05914A (ja)
SE (1) SE443781B (ja)
ZA (1) ZA781697B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5625146A (en) * 1979-05-23 1981-03-10 Meram Lab 33aminopropanesulfonic acid derivative
JP2015504441A (ja) * 2011-11-29 2015-02-12 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ アクリルアミド−２−メチルプロパンスルホン酸（ａ）の塩を生成する方法、アクリルアミド−２−メチルプロパンスルホン酸（ａ）又はその塩、及びそれを用いた共重合体の製造方法

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
US6099869A (en) 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
CA2319272C (en) * 1998-01-27 2005-11-08 Lipha Novel aminoalkanesulphonic, -phosphonic and -phosphinic acid derivatives, their preparation and their use as medicaments
IL146143A0 (en) * 1999-04-28 2002-07-25 Univ Kingston Compositions and methods for treating amyloidosis
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6881750B2 (en) * 2003-03-04 2005-04-19 Nutrition Corp. Of America, Ltd. Potassium taurate bicarbonate and ascorbate
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
US20060167057A1 (en) * 2004-11-16 2006-07-27 Xianqi Kong Compounds for the treatment of CNS and amyloid associated diseases
FR2878160B1 (fr) * 2004-11-19 2008-07-25 Jean Pierre Durlach Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
FI3851447T3 (fi) 2006-10-12 2023-11-15 Bellus Health Inc Menetelmiä, yhdisteitä, koostumuksia ja vehikkeleitä 3-amino-1-propaanisulfonihapon vapauttamiseksi
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
EP2217564A1 (en) * 2007-09-07 2010-08-18 XenoPort, Inc. Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200932734A (en) * 2007-10-15 2009-08-01 Xenoport Inc Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
FR2927809B1 (fr) * 2008-02-26 2011-01-14 Tri Inov Nouvelle utilisation de n-acetyl-taurinate de zinc.
RU2453310C1 (ru) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Средство, обладающее нейропротекторным действием в условиях ишемического поражения мозга и гипоксии, представляющее собой 2-аминоэтансульфонат магния, фармацевтические композиции
FR2973702B1 (fr) 2011-04-08 2013-04-26 Tri Inov N-acetyl-taurinate de zinc pour le traitement du cancer de la prostate
JP6657394B2 (ja) 2015-06-17 2020-03-04 ジーン プロフェット，マーガレット ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤
CN112353789B (zh) * 2015-12-25 2022-05-17 北京乳凝创智生物技术研发中心（有限合伙） 一种化妆品
BE1025644B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement d'une maladie ou d'un trouble du systeme nerveux central chez un sujet en stimulant et/ou en restaurant la plasticite neuronale
BE1025645B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement de la neurotoxicite due a l'hyperexcitabilite des recepteurs glutamatergiques ionotropes
EP3738588A1 (en) 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
PT3738596T (pt) 2019-05-16 2022-06-02 Synapharm Ind Synthesis Composto e composição para utilização no tratamento da síndrome pré-menstrual e/ou distúrbio disfórico pré-menstrual
CA3137407A1 (fr) 2019-05-16 2020-11-19 Synapharm Industrial Synthesis Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
BE1026955B1 (fr) * 2019-06-11 2020-08-04 Synapharm Ind Synthesis Procédé de fabrication de N-acétyl-taurinate de magnésium
RU2731106C1 (ru) * 2019-10-23 2020-08-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(4-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью
RU2730835C1 (ru) * 2019-10-23 2020-08-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(3-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью в сочетании с церебропротективным действием
WO2021245697A1 (en) 2020-06-01 2021-12-09 Celagenex Research (India) Pvt. Ltd. Novel synergistic medicinal compositions for treating dysfunctional d-serine signaling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232968A (en) * 1959-12-01 1966-02-01 Gen Aniline & Film Corp Process for preparing n-acyl taurates using hypophosphorous acid as catalyst
US3344174A (en) * 1962-08-21 1967-09-26 Monsanto Co Vicinal acylamido sulfonate compounds
DE1256650B (de) * 1965-08-07 1967-12-21 Dr Dieter Arlt Verfahren zur Herstellung von N-acylierten 2-Amino-alkan-sulfonsaeuren-(1) bzw. von 2-Amino-alkan-sulfonsaeuren-(1)
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
US3960918A (en) * 1973-06-26 1976-06-01 The Lubrizol Corporation Preparation of esters of amidoalkanesulfonic acids

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5625146A (en) * 1979-05-23 1981-03-10 Meram Lab 33aminopropanesulfonic acid derivative
JPH0317825B2 (ja) * 1979-05-23 1991-03-11 Ru Lab Meramu
JPH03148219A (ja) * 1979-05-23 1991-06-25 Le Lab Meram 膜安定化剤
JPH0524135B2 (ja) * 1979-05-23 1993-04-06 Ru Lab Meramu
JP2015504441A (ja) * 2011-11-29 2015-02-12 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ アクリルアミド−２−メチルプロパンスルホン酸（ａ）の塩を生成する方法、アクリルアミド−２−メチルプロパンスルホン酸（ａ）又はその塩、及びそれを用いた共重合体の製造方法

Also Published As

Publication number Publication date
DE2810918C2 (de) 1985-06-20
AU523705B2 (en) 1982-08-12
OA05914A (fr) 1981-06-30
SE443781B (sv) 1986-03-10
ES468201A1 (es) 1978-12-01
AT356637B (de) 1980-05-12
ZA781697B (en) 1979-03-28
BE865163A (fr) 1978-09-22
US4271189A (en) 1981-06-02
ATA202878A (de) 1979-10-15
GB1599962A (en) 1981-10-07
US4199601A (en) 1980-04-22
SE7803032L (sv) 1978-09-24
IT7867631A0 (it) 1978-03-22
CA1095930A (en) 1981-02-17
CH629479A5 (fr) 1982-04-30
JPS6256867B2 (ja) 1987-11-27
NL7803131A (nl) 1978-09-26
US4267194A (en) 1981-05-12
IT1111455B (it) 1986-01-13
FR2384751B1 (ja) 1979-07-20
FR2384751A1 (fr) 1978-10-20
DE2810918A1 (de) 1978-09-28
GR62093B (en) 1979-02-22
AU3463478A (en) 1979-10-04

Similar Documents

Publication Publication Date Title
JPS53149928A (en) Taurine derivative having nervous muscle activity
GB1543178A (en) Muscle stimulation
JPS5493890A (en) Eyeeground oximeter
JPS54200A (en) Irradiator
JPS5448709A (en) Amine alphaahalomethyl derivative
DE2860390D1 (en) Mandible stimulator
JPS5470275A (en) Benzamide derivative
GB2015872B (en) Anti-sore bed
GB2004613B (en) Camshaft
EG14152A (en) Antitheilerial naphtoquinone derivatives
ZA78413B (en) New therapeutic agents
JPS5460056A (en) Bed
JPS5511563A (en) Movel compound having therapeutic activity
JPS546656A (en) Hosused bed
JPS53117285A (en) Massager
JPS53119225A (en) Plating method
JPS53142329A (en) Plating method
JPS53132194A (en) Ophthalmoscope
JPS5442886A (en) Massager
JPS53119227A (en) Plating method
JPS5412555A (en) Waveform generator
JPS53105087A (en) Massager
PH14662A (en) 1,8-disubstituted carboxtyril derivatives
JPS546393A (en) Ophthalmoscope
JPS53140159A (en) Shelffequipped bed